Quinolones to Significantly Drive Revenue Growth of Urinary Tract Infection Treatment Market

Published On : 2018-09-11

A considerable amount of women suffer from urinary tract infections during their lifetime. On a normal basis, urinary tract infections are treated within 3-14 days antibiotic course. According to the current scenario, urinary tract infections have turned out to be life-threatening as there are high chances that they spread towards bloodstream and kidneys as well.

Quinolones are considered as effective for short duration or single-dose therapy with regards to uncomplicated UTI (urinary tract infections). Single-dose therapies with trimethoprim and fluoroquinolones for the purpose of acute bacterial cystitis result in equivalent efficacy. Several trials were conducted by the researchers that compared fluoroquinolones with ceftazidime, cefadroxil, co-trimoxazole and netilmicin. Most of the fluoroquinolones are likely to be administered in oral and parental forms that enables patients to receive discharge from hospitals as early as possible, which in turn is also a cost-effective option. Fluoroquinolones, especially norfloxacin is also helpful as prophylactic agents to the patients that suffer from regular symptomatic urinary tract infection.

Insights on Fluoroquinolones

Doctors on a larger basis prescribe levofloxacin, ciprofloxacin and various other forms of fluoroquinolones for treating bacterial infections, in particular, UTI (urinary tract infections). Customers can note the point that these drugs are completely regarded as effective and safe against wide-ranging gram-negative and gram-positive bacterial pathogens, thereby making them an ideal choice for body-wide or systemic treatment. Most of all, fluoroquinolones are regarded as being active against facultative anaerobes and aerobes as well. The notable point here is that anaerobes are generally resistant to these drugs. On a broader basis, fluoroquinolones such as levofloxacin and ciprofloxacin are utilized for treating bacterial infections like urinary tract infections.

Apart from all this, fluoroquinolones are hold several essential properties that make it an ideal choice as antibiotics. Four main factors that make them a lucrative choice is:

  1. They can be consumed by mouth and no treatment with injection is needed.

  2. They dispense very well through several body compartments.

  3. Fluoroquinolones hold longer half-life that enables them to get dosed one or two times a day.

  4. Levofloxacin and ciprofloxacin are emitted mostly by kidneys, thereby making them effective for fighting with urinary tract infections.

Insights on Ciprofloxacin

Ciprofloxacin is an antibiotic utilized for treating urinary tract infections. It helps in hindering the proliferation of bacteria, thereby inhibiting repair and reproduction of their DNA (genetic material). Ciprofloxacin is an FDA approved antibiotic which belongs to fluoroquinolones class of antibiotics. Doctors as well as various other medical healthcare experts prescribe Cipro XR and Cipro for treating bacterial infections. One of the main factor behind the occurrence of bacteria leading to UTI (urinary tract infections) are E. coli.

Penicillin and Combinations to Witness Significant Demand

Clinical trials have been carried out for treating UTI (urinary tract infections) with amoxicillin alone, otherwise, amoxicillin with clavulanic acid as well. There are possibilities that patients get treated within 7days time span. No acute side effects or any hematological, biochemical and clinical abnormalities with regards to either treatment. Customers and patients can note the most important point that combination of amoxicillin with clavulanic acid can be beneficial in treating uncomplicated urinary tract infections that are affected due to penicillin-resistant bacteria.

Uncomplicated UTIs (urinary tract infections) are considered as the most commonly encountered infections in outpatient setting. After the respiratory tract infections, UTIs (urinary tract infections) are taken up as the main reasons for increasing production sales of antibiotics. In recent times, level of resistance with regards to pathogens affecting uncomplicated UTIs (urinary tract infections) has risen considerably. Besides, medical world has turned out to be more conscious regarding collateral effects of the systemically applied antibiotics. Various antibiotic agents use a range of particular pressures on both pathogens that are involved in the infections as well as the innocent-observer flora at the similar site. Acknowledgement of this reality has resulted towards an international re-evaluation of the therapeutic references in uncomplicated UTIs (urinary tract infections).